Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-25T09:45:25.517Z Has data issue: false hasContentIssue false
  • English
  • Français

Hydroxyzine Hydrochloride in Familial Restless Legs Syndrome

Published online by Cambridge University Press:  02 December 2014

Roberto Di Fabio ,
Carlo Casali ,
Rita Vadalà  and
Francesco Pierelli
Roberto Di Fabio*
Affiliation:
Department of Neurology and ORL, “Sapienza” University of Rome, Polo Pontino, Latina
Carlo Casali
Affiliation:
Department of Neurology and ORL, “Sapienza” University of Rome, Polo Pontino, Latina
Rita Vadalà
Affiliation:
Department of Radiology, IRCSS San Raffaele Pisana, Rome
Francesco Pierelli
Affiliation:
Headache Clinic, IRCCS Neuromed, Pozzilli, Italy
*
Department of Neurology and ORL, "Sapienza" University of Rome - Polo Pontino, Via Francesco Faggiana 34, 00040 Latina, Italy. Email: [email protected].
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Information
Canadian Journal of Neurological Sciences , Volume 37 , Issue 3 , May 2010 , pp. 406 - 407
Copyright
Copyright © The Canadian Journal of Neurological 2010

References

1. Allen, RP, Picchietti, D, Hening, WA, Trenkwalder, C, Walters, AS, Montplaisi, J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–19.Google Scholar
2. Trenkwalder, C, Högl, B, Winkelmann, J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol. 2009;256(4):539–53.Google Scholar
3. Walters, AS, LeBrocq, C, Dhar, A, Hening, W, Rosen, R, Allen, RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121–32.Google Scholar
4. Lee, SJ, Kim, JS, Song, IU, An, JY, Kim, YI, Lee, KS. Poststroke restless legs syndrome and lesion location: anatomical considerations. Mov Disord. 2009;24(1):77–84.Google Scholar
5. Trenkwalder, C, Hening, WA, Montagna, P, Oertel, WH, Allen, RP, Walters, AS, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008;23(16):2267–302.Google Scholar
6. Tornetta, FJ. A comparison of droperidol, diazepam, and hydroxyzine hydrochloride as premedication. Anesth Analg. 1977;56(4):496–500.Google Scholar
7. Llorca, PM, Spadone, C, Sol, O, Danniau, A, Bougerol, T, Corruble, E, et al. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry. 2002;63(11):1020–7.Google Scholar
8. Shamsi, Z, Hindmarch, I. Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol. 2000;15(S1):S3–30.Google Scholar
9. Dos Santos, RV, Magerl, M, Mlynek, A, Lima, HC. Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines. Ann Allergy Asthma Immunol. 2009;102(6):495–9.Google Scholar
10. Orzechowski, RF, Currie, DS, Valancius, CA. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models. Eur J Pharmacol. 2005;506(3):257–64.Google Scholar
11. Morgan, LK. Restless legs: precipitated by beta blockers, relieved by orphenadrine. Med J Aust. 1975;2(19):753.Google Scholar
12. Cancelli, I, Beltrame, M, Gigli, GL, Valente, M. Drugs with anticholinergic properties: cognitive and neuropsychiatric sideeffects in elderly patients. Neurol Sci. 2009;30(2):87–92.Google Scholar
13. Cervenka, S, Pålhagen, SE, Comley, RA, Panagiotidis, G, Cselényi, Z, Matthews, JC, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129:2017–28.Google Scholar
14. Lima, AR, Weiser, KV, Bacaltchuk, J, Barnes, TR. Anticholinergics for neuroleptic-induced acute akathisia. Cochrane Database Syst. Rev 2004;(1):CD003727.Google Scholar
15. Fulda, S, Wetter, TC. Where dopamine meets opioids: a metaanalysis of the placebo effect in restless legs syndrome treatment studies. Brain. 2008;131:902–17.Google Scholar